|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| Control investments at fair value (cost of $27,353,273 and $27,353,273, respectively) | ||||||||||||||||
| Non-control/non-affiliate investments at fair value (cost of $11,975,431 and $11,882,290, respectively) | ||||||||||||||||
| Investments at fair value | ||||||||||||||||
| Control Investments | ||||||||||||||||
| Non-control/non-affiliate investments | ||||||||||||||||
| Total investments at fair value | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Restricted cash | ||||||||||||||||
| Interest receivable, net of allowance for bad debt of $16,549 and $16,549, respectively | ||||||||||||||||
| Due from portfolio companies | ||||||||||||||||
| Interest receivable, net of allowance for bad debt of $0 and $0, respectively | ||||||||||||||||
| Taxes Receivable | ||||||||||||||||
| Total assets | ||||||||||||||||
| Prepaid expenses | ||||||||||||||||
| Total assets | ||||||||||||||||
| LIABILITIES | ||||||||||||||||
| Accrued management fees | ||||||||||||||||
| Accounts payable | ||||||||||||||||
| Due to affiliates | ||||||||||||||||
| Tax expense payable | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Accrued management fees | ||||||||||||||||
| Accounts payable | ||||||||||||||||
| Due to affiliates | ||||||||||||||||
| Related Party | ||||||||||||||||
| Total due to affiliates | ||||||||||||||||
| Taxes expense payable | ||||||||||||||||
| Deferred fee income | ||||||||||||||||
| Taxes payable | ||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Net assets | ||||||||||||||||
| NET ASSETS | ||||||||||||||||
| Common Stock, par value $0.001 per share (250,000,000 shares authorized; 120,486,061 shares issued and outstanding at June 30, 2026 and December 31, 2025) | ||||||||||||||||
| Paid-in capital | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Total net assets | ||||||||||||||||
| Net asset value per share (in Dollars per share) | ||||||||||||||||
Loading...
